CPA
PGEN icon

Capital Performance Advisors’s Precigen PGEN Stock Holding History

Capital Performance Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$2 – 1965
2024
Q3 		$2 Buy
+2
New +$3 ﹤0.01% 2896

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Performance Advisors's PGEN Position: Q4 2024 in Review

Capital Performance Advisors sold out of Precigen (PGEN) in Q4 2024, closing a stake of 2 shares — an estimated $2 sold.

Capital Performance Advisors first reported a position in PGEN in Q3 2024 and held it in 1 quarter. The position peaked at $2 in Q3 2024. 133 funds tracked by Wall St. Rank hold PGEN as of Q4 2024.

  • Capital Performance Advisors reported no remaining Precigen position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 2 Precigen shares in Q4 2024, an estimated $2.
  • Capital Performance Advisors first reported a position in Precigen in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Precigen position peaked at $2 in Q3 2024.
  • 133 funds tracked by Wall St. Rank held Precigen as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.